Enter inventor name

Axel Monsees

This inventor holds 15 USPTO granted patents and 3 EPO patents. Top assignees: Degussa Aktiengesellschaft, Evonik Degussa Gmbh, Degussa Gmbh. Active years: 2002-2015.

USPTO Granted Patents = 15

% Patents Active = 26.7

EPO Patents = 3

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 37(Granted Patents)

Company Filing History:

8 out of 1,694

Degussa Aktiengesellschaft

Years Active: 2002-2015

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8969624 - Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions (2015-03-03),

2. 8618328 - Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions (2013-12-31),

3. 7834215 - Unsymmetrically substituted phospholane catalysts (2010-11-16),

4. 7763739 - Cycloolefin phosphine ligands and their use in catalysis (2010-07-27),

5. 7612240 - Halophospholanes and their preparation (2009-11-03),

6. 7589215 - Bisphosphines as bidentate ligands (2009-09-15),

7. 7589081 - Nitrogen-containing monodentate phosphines and their use in catalysis (2009-09-15),

8. 7531697 - Process for the preparation of aromatic aldehydes (2009-05-12),

9. 7361786 - Bisphosphines as bidentate ligands (2008-04-22),

10. 7081544 - Chiral ligands, transition metal complexes thereof, and the catalytic use of the same (2006-07-25),

11. 7081533 - Cycloaliphatic/aromatic diphosphines and use thereof in catalysis (2006-07-25),

12. 7015342 - Ferrocenyl ligands and method for the production of such ligands (2006-03-21),

13. 7009065 - Ferrocenyl ligands and the use thereof in catalysis (2006-03-07),

14. 6573389 - Bidentate organophosphorous ligands and their use (2003-06-03),

15. 6476246 - Bidentate phosphorus ligands and their use in catalysis (2002-11-05),

Title: Axel Monsees: Innovator in Phosphine Compounds

Introduction

Axel Monsees is a prominent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of chemistry, particularly in the development of phosphine compounds. With a total of 15 patents to his name, Monsees has established himself as a key figure in innovative chemical research.

Latest Patents

Monsees' latest patents include groundbreaking work on cyclopentadienyl, indenyl, or fluorenyl substituted phosphine compounds and their use in catalytic reactions. These inventions focus on phosphine compounds represented by specific general formulas, detailing the structural components and potential applications in catalytic processes. His work emphasizes the importance of these phosphines as ligands in various chemical reactions, showcasing their versatility and utility in the field.

Career Highlights

Throughout his career, Axel Monsees has worked with notable companies such as Degussa Aktiengesellschaft and Evonik Degussa GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in chemical research and development.

Collaborations

Monsees has collaborated with esteemed colleagues, including Thomas Riermeier and Renat Kadyrov. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of chemistry.

Conclusion

Axel Monsees is a distinguished inventor whose work in phosphine compounds has made a lasting impact on the field of chemistry. His patents and collaborations reflect his commitment to advancing chemical research and innovation.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]